Rock Inhibitor Y-27632 Partially Shields Mouse Testes from Chemotherapy Damage
A ROCK inhibitor partially preserved seminiferous tubule structure and reduced apoptosis in busulfan-treated mice, though sperm parameters remained below control ...
A ROCK inhibitor partially preserved seminiferous tubule structure and reduced apoptosis in busulfan-treated mice, though sperm parameters remained below control ...
A combined genetic, cellular, and mouse study finds that semaglutide strengthens gemcitabine's antitumor effect by suppressing RRM1 while weakening methotrexate ...
A small, single-arm phase II study found a 56.3% response rate with first-line cadonilimab plus PF chemotherapy in 16 patients ...
A retrospective cohort of 2,278 chemotherapy-treated gastrointestinal cancer patients found that 88.1% visited an emergency department and 86.5% were admitted ...
In a prospective, multicenter, single-arm phase II trial conducted at four centers in China, orelabrutinib plus R-CDOP was associated with ...
A FAERS analysis of 786 ifosfamide-related neurological reports found a strong encephalopathy signal, a median onset of two days and ...
A 124-patient randomized trial will test whether probiotics reduce side effects and affect outcomes in advanced or recurrent ovarian cancer, ...
In a two-center observational cohort of 120 patients with advanced NSCLC and COPD, higher serum IL-6 measured after six treatment ...
A 37-patient retrospective cohort found that immune checkpoint inhibitor–containing chemoimmunotherapy was associated with longer overall survival than chemotherapy alone in ...
A longitudinal cohort study of 60 patients at a Western Kenyan referral hospital found earlier changes in kidney-function markers and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine